AngelaChristineHirbeMD

PubMed

• Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics.
  R Taylor Sundby, Jeffrey J Szymanski, Alexander Pan, Paul A Jones, Sana Z Mahmood, Olivia H Reid, Divya Srihari, Amy E Armstrong, Stacey Chamberlain, Sanita Burgic, Ka...> ;Medrxiv. 2024 Mar 11
• A Single Arm Phase 2 Trial of Trametinib in Patients With Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.
  Schuetze, S., Ballman, K., Heise, R., Ganjoo, K., Davis, E., George, S., Burgess, M., Choy, E., Shepard, D., Tinoco, G., Hirbe, A., Kelly, C., Attia, S., Deshpande, H....> ;Clinical Cancer Research. 2024 Mar 6
• CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.
  Jiawan Wang, Ana Calizo, Lindy Zhang, James C Pino, Yang Lyu, Kai Pollard, Xiaochun Zhang, Alex T Larsson, Eric Conniff, Nicolas J Llosa, David K Wood, David A Largaes...> ;Science Advances. 2023 Nov 24
• CSF1 expression in xanthogranulomatous epithelial tumor/keratin-positive giant cell-rich tumor.
  Carina A Dehner, Ying-Chun Lo, Shefali Chopra, Elizabeth G Demicco, Kevin He, Angela C Hirbe, Andrew L Folpe, John S A Chrisinger> ;Human Pathology. 2024 Jan 1
• 1 citations
  Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma.
  Carina A Dehner, Robert C Bell, Yang Cao, Kevin He, John S A Chrisinger, Amy E Armstrong, Marielle Yohe, Jack Shern, Angela C Hirbe> ;JCO Precision Oncology. 2023 Sep 1
• 2 citations
  CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.
  Jordan L Kohlmeyer, Joshua J Lingo, Courtney A Kaemmer, Amanda Scherer, Akshaya Warrier, Ellen Voigt, Juan A Raygoza Garay, Gavin R McGivney, Qierra R Brockman, Amy Ta...> ;Clinical Cancer Research. 2023 Sep 1
• 4 citations
  Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas.
  Amy E Armstrong, Allan J Belzberg, John R Crawford, Angela C Hirbe, Zhihong J Wang> ;BMC Cancer. 2023 Jun 16
• 1 citations
  Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.
  Alex T Larsson, Himanshi Bhatia, Ana Calizo, Kai Pollard, Xiaochun Zhang, Eric Conniff, Justin F Tibbitts, Elizabeth Rono, Katherine Cummins, Sara H Osum, Kyle B Willi...> ;Neuro-Oncology. 2023 Nov 2
• 3 citations
  A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.
  Nam Bui, Hilary Dietz, Sheima Farag, Angela C Hirbe, Michael J Wagner, Brian A Van Tine, Kristen Ganjoo, Robin L Jones, Vicki L Keedy, Elizabeth J Davis> ;Cancers. 2023 May 5
• 1 citations
  The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma.
  Natalie K Heater, Scott Okuno, Steven Robinson, Steven Attia, Mahesh Seetharam, Brittany L Siontis, Janet Yoon, Sant Chawla, Mohammed M Milhem, Varun Monga, Keith Skub...> ;Journal of Clinical Medicine. 2023 Mar 29
• 12 citations
  Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.
  Isidro Cortes-Ciriano, Christopher D Steele, Katherine Piculell, Alyaa Al-Ibraheemi, Vanessa Eulo, Marilyn M Bui, Aikaterini Chatzipli, Brendan C Dickson, Dana C Borch...> ;Cancer Discovery. 2023 Mar 1
• 3 citations
  MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.
  Dana C Borcherding, Neha V Amin, Kevin He, Xiaochun Zhang, Yang Lyu, Carina Dehner, Himanshi Bhatia, Angad Gothra, Layla Daud, Peter Ruminski, Christine A Pratilas, Ka...> ;Clinical Cancer Research. 2023 Apr 14
• CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors.
  Jiawan Wang, Ana Calizo, Lindy Zhang, James C Pino, Yang Lyu, Kai Pollard, Xiaochun Zhang, Alex T Larsson, Eric Conniff, Nicolas Llosa, David K Wood, David A Largaespa...> ;Biorxiv. 2023 Feb 3
• 2 citations
  Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors.
  Carina A Dehner, Tyler Moon, Yang Lyu, Xiaochun Zhang, Zhaohe Zhou, Kuangying Yang, John S A Chrisinger, Anthony Griffin, Jay Wunder, Brendan C Dickson, Angela C Hirbe> ;Genes, Chromosomes & Cancer. 2023 May 1
• 1 citations
  Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast Cancer.
  Samantha K Greaney, Neha Amin, Bethany C Prudner, Maggie Compernolle, Linda J Sandell, Susan C Tebb, Katherine N Weilbaecher, Peri Abeln, Jingqin Luo, Yu Tao, Angela C...> ;Integrative Cancer Therapies. 2022 Nov 22
• 3 citations
  Molecular Characterization of Multifocal Granular Cell Tumors.
  Carina A Dehner, Molly C Schroeder, Yang Lyu, Robert Bell, Dana C Borcherding, Tyler Moon, Angela Hirbe, John S A Chrisinger> ;The American Journal of Surgical Pathology. 2023 Mar 1
• 3 citations
  The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis.
  Lawrence Liu, Carina Dehner, Nikhil Grandhi, Yang Lyu, Dana C Borcherding, John S A Chrisinger, Xiao Zhang, Jingqin Luo, Yu Tao, Amanda Parkes, Nam Q Bui, Elizabeth J ...> ;Genes. 2022 Oct 24
• 2 citations
  Examining patient perspectives on sarcoma surveillance: The Sarcoma Surveillance Survey.
  Sarah C Tepper, Anna K Holten, Donna B Jeffe, Patrick H England, Zachery L Hong, Maria Pérez, Michelle Ghert, Angela C Hirbe, Cara A Cipriano> ;Surgical Oncology. 2022 Dec 1
• 2 citations
  A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.
  Simge Acar, Edwin Nieblas-Bedolla, Amy E Armstrong, Angela C Hirbe> ;Pediatric Neurology. 2022 Sep 1
• 3 citations
  Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy.
  Devon Miller, John A Livingston, Yeonhee Park, Kristi Posey, Sonia Godbole, Keith Skubitz, Steven I Robinson, Mark Agulnik, Lara E Davis, Brian A Van Tine, Angela C Hi...> ;Cancer Medicine. 2022 Sep 1
• 1 citations
  Plexiform neurofibroma: shedding light on the investigational agents in clinical trials.
  Simge Acar, Amy E Armstrong, Angela C Hirbe> ;Expert Opinion on Investigational Drugs. 2022 Jan 1
• Correction: Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.
  Hsiang Chih Lu, Vanessa Eulo, Anthony J. Apicelli, Melike Pekmezci, Yu Tao, Jingqin Luo, Angela C. Hirbe, Sonika Dahiya> ;Oncotarget. 2021 Nov 23
• 1 citations
  Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
  Brian A. Van Tine, Mia C. Weiss, Angela C. Hirbe, Peter Oppelt, Sarah Abaricia, Kathryn Trinkaus, Jingqin Luo, Shellie Berry, Tyler Ruff, Cheryl Callahan, Jacqui Toens...> ;Rare Tumors. 2021 Oct 8
• 11 citations
  Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma
  Carina Dehner, Amy E. Armstrong, Marielle E. Yohe, Jack F. Shern, Angela C. Hirbe> ;Genes. 2021 Sep 25
• 2 citations
  Patterns of Extrapulmonary Metastases in Sarcoma Surveillance
  Zachery Hong, Patrick England, Lee Rhea, Angela C. Hirbe, Douglas J. McDonald, Cara A. Cipriano> ;Cancers. 2021 Sep 17
• Join now to see all